Fredun Pharmaceuticals Limited
In PositoAI's records, Fredun Pharmaceuticals Limited has had 5 dividends since 2021 (₹3.5 per share in total); 1 bonus issue since 2016. Latest dividend: ₹0.7 per share, ex-date 23 Jun 2026.
Records start: dividends 2021, bonus and rights issues 2016, splits and buybacks 2022, mergers and demergers 2025. Earlier actions are not shown.
Fredun Pharmaceuticals Limited Dividend History#
| Ex-date | Dividend |
|---|---|
| 2026 | ₹0.7 per share |
| 23 Jun 2026 | ₹0.7 per share |
| 2025 | ₹0.7 per share |
| 23 Sep 2025 | ₹0.7 per share |
| 2024 | ₹0.7 per share |
| 23 Sep 2024 | ₹0.7 per share |
| 2023 | ₹0.7 per share |
| 22 Sep 2023 | ₹0.7 per share |
| 2021 | ₹0.7 per share |
| 16 Sep 2021 | ₹0.7 per share |
Amounts are per share as declared, not adjusted for later bonus issues or splits.
Fredun Pharmaceuticals Limited Bonus History#
| Ex-date | Details |
|---|---|
| 16 Jul 2026 | 2:1 (2 new shares for every 1 held) |
Questions
Does Fredun Pharmaceuticals Limited pay dividends?
Yes. In PositoAI's records (from 2021), Fredun Pharmaceuticals Limited has paid 5 dividends, the latest ₹0.7 per share with ex-date 23 June 2026.
How much dividend did Fredun Pharmaceuticals Limited pay in 2025?
₹0.7 per share in 2025, in 1 payment.
Has Fredun Pharmaceuticals Limited issued bonus shares?
Yes, 1 time in PositoAI's records (from 2016); the latest was 2:1 (2 new shares for every 1 held) with ex-date 16 July 2026.
What is an ex-date and a record date?
To receive a dividend, bonus or other benefit, you must own the shares before the ex-date. The record date is the day the company checks its list of shareholders.
Records: dividends from 2021, bonus issues and rights issues from 2016, splits and buybacks from 2022, mergers and demergers from 2025; new actions are added every day. Amounts are per share in rupees. To receive a dividend or bonus, shares must be held before the ex-date. Please confirm dates with the company's own announcement. PositoAI is for research and education only and is not investment advice.